MedTrace Logo

Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis

NCT00759148 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1179

Last updated 2018-01-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and efficacy of Moxifloxacin AF Ophthalmic Solution compared to Moxifloxacin AF Vehicle in the treatment of bacterial conjunctivitis in patients one month of age or older.

Conditions

  • Bacterial Conjunctivitis

Interventions

DRUG

Moxifloxacin Alternative Formulation (AF) Ophthalmic Solution 0.5%

Eye drops

OTHER

Moxifloxacin AF Vehicle

Inactive ingredients used as a placebo for masking purposes

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Alcon Research, Ltd. · Alcon Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-03-31
Completion
2010-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00759148 on ClinicalTrials.gov